Showing results (401-410 of 588) with videos related to
Sort By:
Pageof 59
Cancer Treatment Reports|July 1, 1985
Phase I study of vinblastine and verapamil given by concurrent iv infusionA B Benson, D L Trump, J M Koeller, et al.Genes, Chromosomes & Cancer|October 4, 2011
Copy number alterations in prostate tumors and disease aggressivenessIona Cheng, Albert M Levin, Yu Chuan Tai, et al.Plos One|January 22, 2010
Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health StudyIona Cheng, John S Witte, Steven J Jacobsen, et al.AIDS and Behavior|October 28, 2025
Sex Work Stigma as a Partial Mediator Between Social Support and Depressive Symptoms Among Vulnerable Women Engaged in Sex Work in Southern UgandaJoshua Kiyingi, Susan S Witte, Proscovia Nabunya, et al.Journal of Human Behavior in the Social Environment|July 31, 2024
Conducting high-frequency data collection in low-resource settings: Lessons from a financial diary study among women engaged in sex work in UgandaLyla Sunyoung Yang, Susan S Witte, Joshua Kiyingi, et al.American Journal of Epidemiology|March 15, 1997
Plasma carotenoids and the prevalence of adenomatous polyps of the distal colon and rectumJ M Shikany, J S Witte, S M Henning, et al.Journal of the International AIDS Society|May 6, 2021
A cluster-randomized controlled trial of a combination HIV risk reduction and microfinance intervention for female sex workers who use drugs in KazakhstanNabila El-Bassel, Tara McCrimmon, Gaukhar Mergenova, et al.The Journal of Urology|December 3, 2014
Genetic polymorphisms in ESR1 and ESR2 genes, and risk of hypospadias in a multiethnic study populationShweta Choudhry, Laurence S Baskin, Edward J Lammer, et al.The International Journal on Drug Policy|June 6, 2022
Social and structural determinants of health associated with police violence victimization: A latent class analysis of female sex workers who use drugs in KazakhstanTrena I Mukherjee, Andrea Norcini Pala, Assel Terlikbayeva, et al.Cancer|January 1, 1986
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsR S Witte, B Pruitt, D C Tormey, et al.Pageof 59